Literature DB >> 17848696

Scintigraphic imaging of body neuroendocrine tumors.

Charles M Intenzo1, Serge Jabbour, Henry C Lin, Jeffrey L Miller, Sung M Kim, David M Capuzzi, Edith P Mitchell.   

Abstract

Radionuclide imaging is often used in the diagnosis and work-up of a wide range of neoplasms, on the basis of the biologic behavior of the tumor. Neuroendocrine tumors are a subgroup of neoplasms that are generally small and slow growing, and consequently their identification with conventional anatomic imaging can be difficult. Depending on the physiologic properties of the tumor, functional images obtained with radionuclides are often complementary to anatomic images, not only in the localization of the tumor and its metastases, but also in the assessment of prognosis and response to therapy. Familiarity with the choice of the appropriate radiopharmaceutical, proper imaging protocols, and the wide range of imaging patterns will enable the radiologist to guide the clinician in case management. (c) RSNA, 2007.

Entities:  

Mesh:

Year:  2007        PMID: 17848696     DOI: 10.1148/rg.275065729

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  15 in total

Review 1.  Somatostatin receptor expression in non-classical locations - clinical relevance?

Authors:  Eldrin Bhanat; Christian A Koch; Rinkuben Parmar; Vishnu Garla; Vani Vijayakumar
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

2.  Abdominal paragangliomas: a quantitative prognostic score as predictive factor of the feasibility of the laparoscopic approach.

Authors:  Giovanni Alemanno; Carlo Bergamini; Riccardo Somigli; Paolo Prosperi; Alessandro Bruscino; Andrea Valeri
Journal:  Updates Surg       Date:  2017-05-23

3.  111 In-pentetreotide SPECT CT Value in Follow-up of Patients with Neuro-Endocrine Tumors.

Authors:  Badriya Al-Suqri
Journal:  Oman Med J       Date:  2014-09

4.  68Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.

Authors:  Diala El-Maouche; Samira M Sadowski; Georgios Z Papadakis; Lori Guthrie; Candice Cottle-Delisle; Roxanne Merkel; Corina Millo; Clara C Chen; Electron Kebebew; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2016-08-17       Impact factor: 5.958

Review 5.  Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.

Authors:  M Naji; M Hodolic; S El-Refai; S Khan; M C Marzola; D Rubello; A Al-Nahhas
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

6.  A pictoral review on somatostatin receptor scintigraphy in neuroendocrine tumors: The role of multimodality imaging with SRS and GLUT receptor imaging with FDG PET-CT.

Authors:  Sneha Shah; Nilendu Purandare; Archi Agrawal; Venkatesh Rangarajan
Journal:  Indian J Radiol Imaging       Date:  2012-10

7.  Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings.

Authors:  Hilary R Keller; Jessica L Record; Neil U Lall
Journal:  Ochsner J       Date:  2018

8.  MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results.

Authors:  Simone Maurea; Giovanni Fiumara; Teresa Pellegrino; Emilia Zampella; Roberta Assante; Pierpaolo Mainenti; Alberto Cuocolo
Journal:  Cancer Imaging       Date:  2013-04-15       Impact factor: 3.909

Review 9.  Imaging and cancer: a review.

Authors:  Leonard Fass
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 7.449

Review 10.  Pheochromocytoma and paraganglioma: imaging characteristics.

Authors:  Juan C Baez; Jyothi P Jagannathan; Katherine Krajewski; Kevin O'Regan; Katherine Zukotynski; Matthew Kulke; Nikhil H Ramaiya
Journal:  Cancer Imaging       Date:  2012-05-07       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.